SABS
Price:
$3.33
Market Cap:
$31.83M
SAB Biotherapeutics, Inc. is a clinical-stage biopharmaceutical firm dedicated to advancing immunotherapies built upon human antibodies. The company leverages sophisticated genetic engineering and antibody research to cultivate specialized transchromosomic bovine herds. These unique animals are engineered to generate fully human antibodies, which are then directed against a variety of specific ailments. This broad scope includes infectious diseases such as COVID-19 and influenza, various immune and autoimmune conditions like type 1 diabetes, and potential applications in organ transplantation and cancer treatment. Central to their strategy is the proprietary DiversitAb immunotherapy platform...[Read more]
Industry
Biotechnology
IPO Date
2021-02-09
Stock Exchange
NASDAQ
Ticker
SABS
According to SAB Biotherapeutics, Inc.’s latest financial reports and current stock price. The company's current ROE is -0.29%. This represents a change of -98.49% compared to the average of -19.02% of the last 4 quarters.
The mean historical ROE of SAB Biotherapeutics, Inc. over the last ten years is 20.04%. The current -0.29% ROE has changed -101.43% with respect to the historical average. Over the past ten years (40 quarters), SABS's ROE was at its highest in in the September 2025 quarter at 27.53%. The ROE was at its lowest in in the June 2025 quarter at -84.17%.
Average
20.04%
Median
-44.47%
Minimum
-131.33%
Maximum
389.75%
Discovering the peaks and valleys of SAB Biotherapeutics, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 78.34%
Maximum Annual ROE = 389.75%
Minimum Annual Increase = -186.23%
Minimum Annual ROE = -131.33%
| Year | ROE | Change |
|---|---|---|
| 2025 | 8.76% | -106.67% |
| 2024 | -131.33% | 78.34% |
| 2023 | -73.64% | 22.03% |
| 2022 | -60.34% | 35.68% |
| 2021 | -44.47% | -186.23% |
| 2020 | 51.57% | -86.77% |
The current ROE of SAB Biotherapeutics, Inc. (SABS) is greater than its 3-year, greater than its 5-year, and less than than its 10-year historical averages
3-year avg
-65.40%
5-year avg
-60.20%
10-year avg
20.04%
SAB Biotherapeutics, Inc.’s ROE is greater than Verrica Pharmaceuticals Inc. (-1136.50%), less than Pluri Inc. (203.55%), greater than NextCure, Inc. (-186.96%), less than Q32 Bio Inc. (230.68%), greater than AN2 Therapeutics, Inc. (-52.35%), greater than Jasper Therapeutics, Inc. (-523.04%), greater than Evaxion Biotech A/S (-77.79%), less than Iterum Therapeutics plc (602.38%), greater than Boundless Bio, Inc. (-53.60%), greater than Generation Bio Co. (-94.82%),
| Company | ROE | Market cap |
|---|---|---|
| -1136.50% | $61.03M | |
| 203.55% | $20.41M | |
| -186.96% | $5.56M | |
| 230.68% | $161.49M | |
| -52.35% | $129.89M | |
| -523.04% | $7.44M | |
| -77.79% | $22.99M | |
| 602.38% | $1.60M | |
| -53.60% | $31.67M | |
| -94.82% | $35.98M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like SAB Biotherapeutics, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like SAB Biotherapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is SAB Biotherapeutics, Inc.'s ROE?
How is the ROE calculated for SAB Biotherapeutics, Inc. (SABS)?
What is the highest ROE for SAB Biotherapeutics, Inc. (SABS)?
What is the 3-year average ROE for SAB Biotherapeutics, Inc. (SABS)?
What is the 5-year average ROE for SAB Biotherapeutics, Inc. (SABS)?
How does the current ROE for SAB Biotherapeutics, Inc. (SABS) compare to its historical average?